Table of Contents

2019-2024 Global Contraceptives Drugs Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Contraceptives Drugs Consumption 2014-2024
  • 2.1.2 Contraceptives Drugs Consumption CAGR by Region
• 2.2 Contraceptives Drugs Segment by Type
  • 2.2.1 Long-acting Contraceptives
  • 2.2.2 Short-acting Contraceptives
  • 2.2.3 Emergency Contraceptives
• 2.3 Contraceptives Drugs Consumption by Type
  • 2.3.1 Global Contraceptives Drugs Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Contraceptives Drugs Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Contraceptives Drugs Sale Price by Type (2014-2019)
• 2.4 Contraceptives Drugs Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Pharmacy
  • 2.4.3 Other
• 2.5 Contraceptives Drugs Consumption by Application
  • 2.5.1 Global Contraceptives Drugs Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Contraceptives Drugs Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Contraceptives Drugs Sale Price by Application (2014-2019)

3 Global Contraceptives Drugs by Players

• 3.1 Global Contraceptives Drugs Sales Market Share by Players
  • 3.1.1 Global Contraceptives Drugs Sales by Players (2017-2019)
  • 3.1.2 Global Contraceptives Drugs Sales Market Share by Players (2017-2019)
• 3.2 Global Contraceptives Drugs Revenue Market Share by Players
  • 3.2.1 Global Contraceptives Drugs Revenue by Players (2017-2019)
  • 3.2.2 Global Contraceptives Drugs Revenue Market Share by Players (2017-2019)
• 3.3 Global Contraceptives Drugs Sale Price by Players
• 3.4 Global Contraceptives Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Contraceptives Drugs Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Contraceptives Drugs Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Contraceptives Drugs by Regions

• 4.1 Contraceptives Drugs by Regions
  • 4.1.1 Global Contraceptives Drugs Consumption by Regions
  • 4.1.2 Global Contraceptives Drugs Value by Regions
• 4.2 Americas Contraceptives Drugs Consumption Growth
• 4.3 APAC Contraceptives Drugs Consumption Growth
• 4.4 Europe Contraceptives Drugs Consumption Growth
• 4.5 Middle East & Africa Contraceptives Drugs Consumption Growth

5 Americas

• 5.1 Americas Contraceptives Drugs Consumption by Countries
  • 5.1.1 Americas Contraceptives Drugs Consumption by Countries (2014-2019)
  • 5.1.2 Americas Contraceptives Drugs Value by Countries (2014-2019)
• 5.2 Americas Contraceptives Drugs Consumption by Type
• 5.3 Americas Contraceptives Drugs Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Contraceptives Drugs Consumption by Countries
  • 6.1.1 APAC Contraceptives Drugs Consumption by Countries (2014-2019)
  • 6.1.2 APAC Contraceptives Drugs Value by Countries (2014-2019)
• 6.2 APAC Contraceptives Drugs Consumption by Type
• 6.3 APAC Contraceptives Drugs Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Contraceptives Drugs by Countries
  • 7.1.1 Europe Contraceptives Drugs Consumption by Countries (2014-2019)
  • 7.1.2 Europe Contraceptives Drugs Value by Countries (2014-2019)
• 7.2 Europe Contraceptives Drugs Consumption by Type
• 7.3 Europe Contraceptives Drugs Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Contraceptives Drugs by Countries
  • 8.1.1 Middle East & Africa Contraceptives Drugs Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Contraceptives Drugs Value by Countries (2014-2019)
• 8.2 Middle East & Africa Contraceptives Drugs Consumption by Type
• 8.3 Middle East & Africa Contraceptives Drugs Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Contraceptives Drugs Distributors
• 10.3 Contraceptives Drugs Customer

11 Global Contraceptives Drugs Market Forecast

• 11.1 Global Contraceptives Drugs Consumption Forecast (2019-2024)
• 11.2 Global Contraceptives Drugs Forecast by Regions
  • 11.2.1 Global Contraceptives Drugs Forecast by Regions (2019-2024)
  • 11.2.2 Global Contraceptives Drugs Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Contraceptives Drugs Forecast by Type
• 11.8 Global Contraceptives Drugs Forecast by Application

12 Key Players Analysis

• 12.1 Bayer
  • 12.1.1 Company Details
  • 12.1.2 Contraceptives Drugs Product Offered
  • 12.1.3 Bayer Contraceptives Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Bayer News
• 12.2 Pfizer
  • 12.2.1 Company Details
  • 12.2.2 Contraceptives Drugs Product Offered
  • 12.2.3 Pfizer Contraceptives Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Pfizer News
• 12.3 Teva Pharmaceutical
  • 12.3.1 Company Details
  • 12.3.2 Contraceptives Drugs Product Offered
  • 12.3.3 Teva Pharmaceutical Contraceptives Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Teva Pharmaceutical News
• 12.4 Merck
  • 12.4.1 Company Details
  • 12.4.2 Contraceptives Drugs Product Offered
  • 12.4.3 Merck Contraceptives Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Merck News
• 12.5 Actavis
  • 12.5.1 Company Details
  • 12.5.2 Contraceptives Drugs Product Offered
  • 12.5.3 Actavis Contraceptives Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Actavis News
• 12.6 Johnson & Johnson
  • 12.6.1 Company Details
  • 12.6.2 Contraceptives Drugs Product Offered
  • 12.6.3 Johnson & Johnson Contraceptives Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Johnson & Johnson News
• 12.7 Gedeon Richter
  • 12.7.1 Company Details
  • 12.7.2 Contraceptives Drugs Product Offered
  • 12.7.3 Gedeon Richter Contraceptives Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Gedeon Richter News
• 12.8 Novo Nordisk A/S
  • 12.8.1 Company Details
  • 12.8.2 Contraceptives Drugs Product Offered
  • 12.8.3 Novo Nordisk A/S Contraceptives Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Novo Nordisk A/S News
• 12.9 ZiZhu
  • 12.9.1 Company Details
  • 12.9.2 Contraceptives Drugs Product Offered
  • 12.9.3 ZiZhu Contraceptives Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 ZiZhu News
• 12.10 Baijingyu
  • 12.10.1 Company Details
  • 12.10.2 Contraceptives Drugs Product Offered
  • 12.10.3 Baijingyu Contraceptives Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Baijingyu News
• 12.11 Huazhong

13 Research Findings and Conclusion

Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.

According to this study, over the next five years the Contraceptives Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Contraceptives Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptives Drugs market by product type, application, key manufacturers and key regions and countries.

This study considers the Contraceptives Drugs value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Pharmacy
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Pfizer
Teva Pharmaceutical
Merck
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Contraceptives Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Contraceptives Drugs market by identifying its various subsegments.
Focuses on the key global Contraceptives Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Contraceptives Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Contraceptives Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.